First, the testing of therapeutic gene vectors in vitro is described. This is followed by a discussion of the administration of therapeutic vectors in vivo. Two methods for assessing the development of anti-tumor immunity after cytokine gene therapy are provided. In addition, two methods for the generation of murine tumor models in syngeneic hostsone subcutaneous and one orthotopicare also included.
|Original language||English (US)|
|Journal||Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.]|
|State||Published - Jan 1 2001|
ASJC Scopus subject areas